Font Size: a A A
Keyword [Wild-type]
Result: 121 - 140 | Page: 7 of 10
121. The Activity Of FNC To Different HBV-transfered Wild And Dual Drug-resistant Cells In Vitro And HBV-transgenic Mice In Vivo
122. The Function And Mechanism Research Of MiR612 Associated With Esophageal Squamous Cell Carcinoma Metastasis Mediated Through P53
123. Interactions Between Mutant And Wild-type Lactate Dehydrogenase C4 Subunits: A Novel Dominant Negative Mechanism
124. The Research On Effect Of Different Administration Sequences Of Docetaxel,Cetuximab And Bevacizumab In KRAS Wild Type Lung Cancer Xenograft Model
125. Anti-tumor Activity Of High-dose EGFR Tyrosine Kinase Inhibitor Combined With Docetaxel Against Lung Cancer With EGFR Wild Type In Vivo
126. The Exploratory Study Of Individualized Tumor Vaccine Prepared With Pemetrexed Combined With DC-CIK On Advanced EGFR Wild-type Adenocarcinoma Lung Cancer
127. Expression Of Wild-type P53-induced Phosphatase 1 In Diabetic Epiretinal Membranes
128. Isolated FSH Deficiency: In Vitro Validation Experiments Of Wild-type And Mutant P.Arg97X FSH? Subunit
129. The Structure,Function And Stability Of IDH2 Mutants In AML And Other Tumors
130. To Investigate The Prognostic Factors And The Significance Of TKI In Advanced NSCLC With Wild-type EGFR
131. A Retrospective Study Of Yifei Sanjie Formula In The Treatment Of ? Stage Wild-type EGFR Non-small Cell Lung Cancer
132. Network Meta-analysis Of Subsequent Treatments Of EGFR-WT And Unknown EGFR Mutation In Patients With Advanced Non-small Cell Lung Cancer
133. Phase ? Study Of High-dose Pemetrexed Plus Cisplatin In The Treatment Of Patients With Brain Metastases From Lung Adenocarcinoma (Wild Type)
134. Clinical Research On Anti-lung Tumor Ointment Combined With Chemotherapy Improving Survival Status Of Advanced EGFR Wild-type NSCLC
135. Nutlin-3,An Antagonist Of MDM2,Enhances The Radiosensitivity Of Esophageal Squamous Cancer With Wild-type P53
136. Clinical Evaluation On Quality Of Life In Patients With EGFR Wild-type NSCLC Treated With Lung Tumor Suppression Paste
137. Expression Difference And Prognostic Significance Of CD7 In AML Patients With Wild Type And Mutant Of CEBPA
138. Study On Induced Mutation From CCR5 Wild Type To CCR5?32 In Lymphoid Cells By Using CRISPR/Cas Gene Editing System
139. Wild Type P53 Produces Chemotherapy Resistance Related To Its Cell Location In Cancer Cell
140. A Study On Relationship Between TCM Syndrome Differentiation And RAS And BRAF Genes In Left And Right Colon Cancer
  <<First  <Prev  Next>  Last>>  Jump to